Abstract
Perfluoroalkyl compounds (PFCs) are a class of organic molecules used in industry and consumer products. PFCs are non-biodegradable and bioaccumulate in the environment and for these reasons they have been a major subject of research regarding their toxicity, environmental fate, and sources of human exposure, since they have been shown to induce severe health consequences, such as neonatal mortality, neurotoxicity and immunotoxicity. The aim of this review is to explore the existing knowledge of the interplay between PFCs exposure and human health, with a focus on male reproductive health, given the emerging gender differences in PFCs clearance and their interaction with sex hormones receptors. A comprehensive PUBMED search was performed using relevant key terms for PFCs and male fertility. Different degrees of evidence suggest an impairment of semen parameters and sex hormones in relation to PFCs exposure. These preliminary results point towards a sex-dependent pharmacodynamics and clearance, with males having a much higher tendency to accumulation. Moreover, because of the widespread environmental occurrence of these chemicals, along with their ability to cross the placental barrier, exposure of the foetus to these compounds is inevitable. This is of concern because foetal development of the male reproductive organs may be disturbed by exposure to exogenous factors. These findings clearly suggest an antiandrogenic potential of PFCs and a link between endocrine disruptors and disorders of male health.
Similar content being viewed by others
References
Conder JM, Hoke RA, De Wolf W et al (2008) Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ Sci Technol 42:995–1003
Steenland K, Fletcher T, Savitz DA (2010) Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 118:1100–1108. https://doi.org/10.1289/ehp.0901827
Giesy JP, Kannan K (2002) Perfluorochemical surfactants in the environment. Environ Sci Technol 36:146A–152A
Han X, Snow TA, Kemper RA, Jepson GW (2003) Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 16:775–781. https://doi.org/10.1021/tx034005w
Fromme H, Tittlemier SA, Völkel W et al (2009) Perfluorinated compounds—exposure assessment for the general population in western countries. Int J Hyg Environ Health 212:239–270. https://doi.org/10.1016/j.ijheh.2008.04.007
Olsen GW, Lange CC, Ellefson ME et al (2012) Temporal trends of perfluoroalkyl concentrations in American Red Cross Adult Blood Donors, 2000–2010. Environ Sci Technol 46:6330–6338. https://doi.org/10.1021/es300604p
Raymer JH, Michael LC, Studabaker WB et al (2012) Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements. Reprod Toxicol 33:419–427. https://doi.org/10.1016/j.reprotox.2011.05.024
Kubwabo C, Kosarac I, Lalonde K (2013) Determination of selected perfluorinated compounds and polyfluoroalkyl phosphate surfactants in human milk. Chemosphere 91:771–777. https://doi.org/10.1016/j.chemosphere.2013.02.011
Kim S, Choi K, Ji K et al (2011) Trans-placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ Sci Technol 45:7465–7472. https://doi.org/10.1021/es202408a
Maestri L, Negri S, Ferrari M et al (2006) Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. Rapid Commun Mass Spectrom 20:2728–2734. https://doi.org/10.1002/rcm.2661
Haug LS, Huber S, Becher G, Thomsen C (2011) Characterisation of human exposure pathways to perfluorinated compounds—comparing exposure estimates with biomarkers of exposure. Environ Int 37:687–693. https://doi.org/10.1016/j.envint.2011.01.011
Apelberg BJ, Goldman LR, Calafat AM et al (2007) Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol 41:3891–3897
Needham LL, Grandjean P, Heinzow B et al (2011) Partition of environmental chemicals between maternal and fetal blood and tissues. Environ Sci Technol 45:1121–1126. https://doi.org/10.1021/es1019614
Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972–978
Lau C (2012) Perfluorinated compounds. In: EXS. pp 47–86
Biegel LB, Liu RCM, Hurtt ME, Cook JC (1995) Effects of ammonium perfluorooctanoate on leydig-cell function. In Vitro, in Vivo, and ex Vivo Studies. Toxicol Appl Pharmacol 134:18–25. https://doi.org/10.1006/taap.1995.1164
Shi Z, Zhang H, Liu Y et al (2007) Alterations in gene expression and testosterone synthesis in the testes of male rats exposed to perfluorododecanoic acid. Toxicol Sci 98:206–215. https://doi.org/10.1093/toxsci/kfm070
Wan HT, Zhao YG, Wong MH et al (2011) Testicular signaling is the potential target of perfluorooctanesulfonate-mediated subfertility in male Mice. Biol Reprod 84:1016–1023. https://doi.org/10.1095/biolreprod.110.089219
Zhang H, Lu Y, Luo B et al (2014) Proteomic analysis of mouse testis reveals perfluorooctanoic acid-induced reproductive dysfunction via direct disturbance of testicular steroidogenic machinery. J Proteome Res 13:3370–3385. https://doi.org/10.1021/pr500228d
Kang JS, Choi JS, Park JW (2016) Transcriptional changes in steroidogenesis by perfluoroalkyl acids (PFOA and PFOS) regulate the synthesis of sex hormones in H295R cells. Chemosphere 155:436–443. https://doi.org/10.1016/j.chemosphere.2016.04.070
Joensen UN, Bossi R, Leffers H et al (2009) Do Perfluoroalkyl compounds impair human semen quality? Environ Health Perspect 117:923–927. https://doi.org/10.1289/ehp.0800517
Joensen UN, Veyrand B, Antignac JP et al (2013) PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men. Hum Reprod 28:599–608. https://doi.org/10.1093/humrep/des425
Specht IO, Hougaard KS, Spanò M et al (2012) Sperm DNA integrity in relation to exposure to environmental perfluoroalkyl substances—a study of spouses of pregnant women in three geographical regions. Reprod Toxicol 33:577–583. https://doi.org/10.1016/j.reprotox.2012.02.008
Louis GMB, Chen Z, Schisterman EF et al (2015) Perfluorochemicals and human semen quality: the LIFE study. Environ Health Perspect 123:57–63. https://doi.org/10.1289/ehp.1307621
Toft G, Jönsson BAG, Lindh CH et al (2012) Exposure to perfluorinated compounds and human semen quality in arctic and European populations. Hum Reprod 27:2532–2540. https://doi.org/10.1093/humrep/des185
Governini L, Guerranti C, De Leo V et al (2015) Chromosomal aneuploidies and DNA fragmentation of human spermatozoa from patients exposed to perfluorinated compounds. Andrologia 47:1012–1019. https://doi.org/10.1111/and.12371
López-Doval S, Salgado R, Pereiro N et al (2014) Perfluorooctane sulfonate effects on the reproductive axis in adult male rats. Environ Res 134:158–168. https://doi.org/10.1016/j.envres.2014.07.006
López-Doval S, Salgado R, Fernández-Pérez B, Lafuente A (2015) Possible role of serotonin and neuropeptide Y on the disruption of the reproductive axis activity by perfluorooctane sulfonate. Toxicol Lett 233:138–147. https://doi.org/10.1016/j.toxlet.2015.01.012
Pereiro N, Moyano R, Blanco A, Lafuente A (2014) Regulation of corticosterone secretion is modified by PFOS exposure at different levels of the hypothalamic–pituitary–adrenal axis in adult male rats. Toxicol Lett 230:252–262. https://doi.org/10.1016/j.toxlet.2014.01.003
Qiu L, Zhang X, Zhang X et al (2013) Sertoli cell is a potential target for perfluorooctane sulfonate-induced reproductive dysfunction in male mice. Toxicol Sci 135:229–240. https://doi.org/10.1093/toxsci/kft129
Jensen AA, Leffers H (2008) Emerging endocrine disrupters: perfluoroalkylated substances. Int J Androl 31:161–169. https://doi.org/10.1111/j.1365-2605.2008.00870.x
Zhang Y, Beesoon S, Zhu L, Martin JW (2013) Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. Environ Sci Technol 47:10619–10627. https://doi.org/10.1021/es401905e
López-Doval S, Salgado R, Lafuente A (2016) The expression of several reproductive hormone receptors can be modified by perfluorooctane sulfonate (PFOS) in adult male rats. Chemosphere 155:488–497. https://doi.org/10.1016/j.chemosphere.2016.04.081
Vested A, Ramlau-Hansen CH, Olsen SF et al (2013) Associations of in Utero exposure to perfluorinated alkyl acids with human semen quality and reproductive hormones in adult men. Environ Health Perspect 121:453–458. https://doi.org/10.1289/ehp.1205118
La Rocca C, Alessi E, Bergamasco B et al (2012) Exposure and effective dose biomarkers for perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in infertile subjects: preliminary results of the PREVIENI project. Int J Hyg Environ Health 215:206–211. https://doi.org/10.1016/j.ijheh.2011.10.016
La Rocca C, Tait S, Guerranti C et al (2015) Exposure to endocrine disruptors and nuclear receptors gene expression in infertile and fertile men from Italian areas with different environmental features. Int J Environ Res Public Health 12:12426–12445. https://doi.org/10.3390/ijerph121012426
Dehm SM, Tindall DJ (2007) Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol Endocrinol 21:2855–2863. https://doi.org/10.1210/me.2007-0223
Gao W, Bohl CE, Dalton JT (2005) Chemistry and structural biology of androgen receptor. Chem Rev 105:3352–3370. https://doi.org/10.1021/cr020456u
Kjeldsen LS, Bonefeld-Jørgensen EC (2013) Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res 20:8031–8044. https://doi.org/10.1007/s11356-013-1753-3
Luccio-Camelo DC, Prins GS (2011) Disruption of androgen receptor signaling in males by environmental chemicals. J Steroid Biochem Mol Biol 127:74–82. https://doi.org/10.1016/j.jsbmb.2011.04.004
Paoli D, Giannandrea F, Gallo M et al (2015) Exposure to polychlorinated biphenyls and hexachlorobenzene, semen quality and testicular cancer risk. J Endocrinol Invest 38:745–752. https://doi.org/10.1007/s40618-015-0251-5
Austin ME, Kasturi BS, Barber M et al (2003) Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ Health Perspect 111:1485–1489
Li N, Mruk DD, Chen H et al (2016) Rescue of perfluorooctanesulfonate (PFOS)-mediated Sertoli cell injury by overexpression of gap junction protein connexin 43. Sci Rep 6:29667. https://doi.org/10.1038/srep29667
Kim SJ, Heo SH, Lee DS et al (2016) Gender differences in pharmacokinetics and tissue distribution of 3 perfluoroalkyl and polyfluoroalkyl substances in rats. Food Chem Toxicol 97:243–255. https://doi.org/10.1016/j.fct.2016.09.017
Chang S-C, Noker PE, Gorman GS et al (2012) Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys. Reprod Toxicol 33:428–440. https://doi.org/10.1016/j.reprotox.2011.07.002
Hundley SG, Sarrif AM, Kennedy GL (2006) Absorption, distribution, and excretion of ammonium perfluorooctanoate (APFO) after oral administration to various species. Drug Chem Toxicol 29:137–145. https://doi.org/10.1080/01480540600561361
Hanhijärvi H, Ylinen M, Haaranen T, Nevalainen T (1988) A proposed species difference in the renal excretion of perfluoro octanoic acid in the Beagle dog and rat. In: New developments in biosciences: their implications for laboratory animal science. Springer Netherlands, Dordrecht, pp 409–412
Weaver YM, Ehresman DJ, Butenhoff JL, Hagenbuch B (2010) Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths. Toxicol Sci 113:305–314. https://doi.org/10.1093/toxsci/kfp275
Butenhoff JL, Kennedy GL, Hinderliter PM et al (2004) Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. Toxicol Sci 82:394–406. https://doi.org/10.1093/toxsci/kfh302
Lau C, Anitole K, Hodes C et al (2007) Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 99:366–394. https://doi.org/10.1093/toxsci/kfm128
Nakayama S, Harada K, Inoue K et al (2005) Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities. Environ Sci 12:293–313
Kudo N, Kawashima Y (2003) Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J Toxicol Sci 28:49–57
Kennedy GL, Butenhoff JL, Olsen GW et al (2004) The toxicology of perfluorooctanoate. Crit Rev Toxicol 34:351–384
Olsen GW, Burris JM, Ehresman DJ et al (2007) Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 115:1298–1305. https://doi.org/10.1289/ehp.10009
Brede E, Wilhelm M, Göen T et al (2010) Two-year follow-up biomonitoring pilot study of residents’ and controls’ PFC plasma levels after PFOA reduction in public water system in Arnsberg, Germany. Int J Hyg Environ Health 213:217–223. https://doi.org/10.1016/j.ijheh.2010.03.007
Bartell SM, Calafat AM, Lyu C et al (2010) Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect 118:222–228. https://doi.org/10.1289/ehp.0901252
Tan Y-M, Clewell HJ, Andersen ME (2008) Time dependencies in perfluorooctylacids disposition in rat and monkeys: a kinetic analysis. Toxicol Lett 177:38–47. https://doi.org/10.1016/j.toxlet.2007.12.007
Cui L, Liao C, Zhou Q et al (2010) Excretion of PFOA and PFOS in male rats during a subchronic exposure. Arch Environ Contam Toxicol 58:205–213. https://doi.org/10.1007/s00244-009-9336-5
Han X, Nabb DL, Russell MH et al (2012) Renal elimination of perfluorocarboxylates (PFCAs). Chem Res Toxicol 25:35–46. https://doi.org/10.1021/tx200363w
Fu J, Gao Y, Cui L et al (2016) Occurrence, temporal trends, and half-lives of perfluoroalkyl acids (PFAAs) in occupational workers in China. Sci Rep 6:38039. https://doi.org/10.1038/srep38039
Harada K, Inoue K, Morikawa A et al (2005) Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion. Environ Res 99:253–261. https://doi.org/10.1016/j.envres.2004.12.003
Nakagawa H, Terada T, Harada KH et al (2009) Human organic anion transporter hOAT4 is a transporter of perfluorooctanoic acid. Basic Clin Pharmacol Toxicol 105:136–138. https://doi.org/10.1111/j.1742-7843.2009.00409.x
Kudo N, Katakura M, Sato Y, Kawashima Y (2002) Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem Biol Interact 139:301–316. https://doi.org/10.1016/S0009-2797(02)00006-6
Fei C, McLaughlin JK, Tarone RE, Olsen J (2007) Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115:1677–1682. https://doi.org/10.1289/ehp.10506
Inoue K, Okada F, Ito R et al (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 112:1204–1207
Post GB, Cohn PD, Cooper KR (2012) Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. Environ Res 116:93–117. https://doi.org/10.1016/j.envres.2012.03.007
Cho E, Montgomery RB, Mostaghel EA (2014) Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression. Endocrinology 155:4124–4132. https://doi.org/10.1210/en.2014-1337
Barry V, Winquist A, Steenland K (2013) Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect 121:1313–1318. https://doi.org/10.1289/ehp.1306615
Vieira VM, Hoffman K, Shin HM et al (2013) Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis. Environ Health Perspect 121:318–323. https://doi.org/10.1289/ehp.1205829
Eriksen KT, Sorensen M, McLaughlin JK et al (2009) Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general danish population. J Natl Cancer Inst 101:605–609. https://doi.org/10.1093/jnci/djp041
Buhrke T, Kibellus A, Lampen A (2013) In vitro toxicological characterization of perfluorinated carboxylic acids with different carbon chain lengths. Toxicol Lett 218:97–104. https://doi.org/10.1016/j.toxlet.2013.01.025
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest regarding the publication of this paper.
Ethical approval
This article does not contain studies with human participants or animals performed by any of the authors.
Informed consent
No informed consent.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Foresta, C., Tescari, S. & Di Nisio, A. Impact of perfluorochemicals on human health and reproduction: a male’s perspective. J Endocrinol Invest 41, 639–645 (2018). https://doi.org/10.1007/s40618-017-0790-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-017-0790-z